Your session is about to expire
← Back to Search
Virus Therapy
COVID 19 Convalescent Plasma for Coronavirus
Phase 1
Waitlist Available
Led By Eric Salazar, MD, PhD
Research Sponsored by The Methodist Hospital Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Recipient must meet criteria outlined in the recent Investigational COVID-19 Convalescent Plasma - Emergency INDs (investigational new drug) guidance (https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/investigational-covid-19-convalescent-plasma-emergency-inds)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 60 days post-transfusion
Awards & highlights
Study Summary
This study is evaluating whether convalescent plasma is safe and effective for treating COVID-19.
Eligible Conditions
- Coronavirus
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 60 days post-transfusion
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 60 days post-transfusion
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Cumulative incidence of serious adverse events related to the treatment intervention.
Mortality at Day 28 post-hospital admission.
Secondary outcome measures
Length of ICU stay
Length of hospital stay
Mechanical ventilation
+1 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: TreatmentExperimental Treatment1 Intervention
All subjects recruited will be transfused with COVID 19 convalescent plasma. A prospective comparison with matched historical controls receiving standard care will be employed.
Find a Location
Who is running the clinical trial?
The Methodist Hospital Research InstituteLead Sponsor
270 Previous Clinical Trials
79,908 Total Patients Enrolled
Eric Salazar, MD, PhDPrincipal InvestigatorThe Methodist Hospital Research Institute
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger